A class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors may support reduce the risk of dementia and Parkinson’s disease, a recent study suggests. SGLT2, also known as gliflozin, works by lowering blood sugar levels by helping the kidneys remove sugar from the body through urine. In a novel study published in the journal Neurology, […]
Excess body weight increases the risk of neurodegenerative diseases, but studies have shown that it is not always just the total body weight that matters, but also the body composition. Scientists have found that people who store fat around their abdomen and arms have a higher risk of developing Alzheimer’s and Parkinson’s disease compared to […]
A recent study found that anxiety can double the risk of developing Parkinson’s disease in adults over the age of 50. Parkinson’s disease is a neurodegenerative disease that affects the lives of almost 10 million people around the world. It is a progressive disorder caused by the death or damage of nerve cells in the […]
